Short description
Anelixis Therapeutics is a biotechnology company that facilitates pre-clinical drug development.
Description
Anelixis Therapeutics is a clinical stage development company located in Cambridge, Massachusetts with a portfolio focused on immune modulatory drugs for neurodegenerative diseases with a focus on amyotrophic lateral sclerosis (ALS) and Alzheimer's Disease (AD).
Anelixis Therapeutics is committed to advancing treatments that will have a meaningful impact on the lives of patients by helping them battle back their disease progression.
Last funding
Noaccess
Sign in for full access
Total funding
$$43214321
Sign in for full access
Location
Cambridge, Massachusetts, United States, North America
Founded on
January 1, 2012
Exited on
September 14, 2020
Non-profit?
No
Acquired?
No
Employees count
1-10
Revenue range
$56378 - 90123
Sign in for full access
Founders
Steve Perrin